These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33835414)

  • 21. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
    Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
    Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
    Xin Y; McIntosh E
    Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.
    Koszorú K; Hajdu K; Brodszky V; Bató A; Gergely LH; Kovács A; Beretzky Z; Sárdy M; Szegedi A; Rencz F
    Eur J Health Econ; 2023 Feb; 24(1):139-152. PubMed ID: 35412162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.
    Chuang LH; Cohen AT; Agnelli G; Gumbs PD; Bauersachs R; Kroep S; Gitt AK; Monreal M; Willich SN; van Hout B
    Qual Life Res; 2019 May; 28(5):1155-1177. PubMed ID: 30607785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.
    Herdman M; Kerr C; Pavesi M; Garside J; Lloyd A; Cubi-Molla P; Devlin N
    J Patient Rep Outcomes; 2020 Mar; 4(1):22. PubMed ID: 32219576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
    Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
    Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.
    Bató A; Brodszky V; Gergely LH; Gáspár K; Wikonkál N; Kinyó Á; Szabó Á; Beretzky Z; Szegedi A; Remenyik É; Kiss N; Sárdy M; Rencz F
    Qual Life Res; 2021 May; 30(5):1477-1490. PubMed ID: 33534032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders.
    Grochtdreis T; König HH; Keetharuth AD; Gallinat J; Konnopka A; Schulz H; Lambert M; Karow A; Dams J
    Eur J Health Econ; 2023 Jun; 24(4):499-512. PubMed ID: 35776388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.
    Brazier J; Connell J; Papaioannou D; Mukuria C; Mulhern B; Peasgood T; Jones ML; Paisley S; O'Cathain A; Barkham M; Knapp M; Byford S; Gilbody S; Parry G
    Health Technol Assess; 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PubMed ID: 24857402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
    Jankowska A; Młyńczak K; Golicki D
    Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
    Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety.
    Sandin K; Shields G; Gjengedal RGH; Osnes K; Bjørndal MT; Reme SE; Hjemdal O
    Health Qual Life Outcomes; 2023 Apr; 21(1):35. PubMed ID: 37061712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric properties of the EQ-5D-5L in the general population of South Korea.
    Kim TH; Jo MW; Lee SI; Kim SH; Chung SM
    Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China.
    Weng G; Hong Y; Luo N; Mukuria C; Jiang J; Yang Z; Li S
    Eur J Health Econ; 2023 Mar; 24(2):197-207. PubMed ID: 35538178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability, Validity and Responsiveness of the EQ-5D-5L in Assessing and Valuing Health Status in Adolescents and Young Adults with Posttraumatic Stress Disorder: a Randomized Controlled Trail.
    Dams J; Rimane E; Steil R; Renneberg B; Rosner R; König HH
    Psychiatr Q; 2021 Jun; 92(2):459-471. PubMed ID: 32803473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.